Triso NIM® is a PRENATAL NON-INVASIVE SCREENING TEST that can detect in maternal blood fetal trisomies of chromosomes 13, 18 and 21, the most common aneuploidies of the sexual chromosomes and certain genetic microdeletion syndromes. It combines the sure and effective, NEXT GENERATION SEQUENCING (NGS) together with advanced bioinformatics analysis.
If you never did malware analysis before, the material presented can be overwhelming.
It’s not easy to immediately put what you learned into action (you might understand a subject theoretically but might not be comfortable enough with the subject to put it into practice).
2.- Position Statement from the Aneuploidy Screening Committee on Behalf of the Board of the International Society for Prenatal Diagnosis ISPD Position Statement 4 April 2013.
This statement replaces, January 2011 Statement ( Prenatal Diagnosis 2011, 9-522) and the rapid response statement (Prenatal Diagnosis 20;1-2).
If your complaint has already been raised with our customer care team and if you have not received a satisfactory response and would like to escalate it further for investigation please do e-mail us on [email protected] aim to resolve your complaint as soon as possible and will keep you updated on when and how we propose to resolve it.